These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17287415)

  • 1. Functional characterization of naturally occurring NR3C2 gene mutations in Italian patients suffering from pseudohypoaldosteronism type 1.
    Balsamo A; Cicognani A; Gennari M; Sippell WG; Menabò S; Baronio F; Riepe FG
    Eur J Endocrinol; 2007 Feb; 156(2):249-56. PubMed ID: 17287415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
    Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel frameshift mutation in NR3C2 leads to decreased expression of mineralocorticoid receptor: a family with renal pseudohypoaldosteronism type 1.
    Kawashima Sonoyama Y; Tajima T; Fujimoto M; Hasegawa A; Miyahara N; Nishimura R; Hashida Y; Hayashi A; Hanaki K; Kanzaki S
    Endocr J; 2017 Jan; 64(1):83-90. PubMed ID: 27725360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid receptor mutations differentially affect individual gene expression profiles in pseudohypoaldosteronism type 1.
    Fernandes-Rosa FL; Hubert EL; Fagart J; Tchitchek N; Gomes D; Jouanno E; Benecke A; Rafestin-Oblin ME; Jeunemaitre X; Antonini SR; Zennaro MC
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E519-27. PubMed ID: 21159846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.
    Fernandes-Rosa FL; de Castro M; Latronico AC; Sippell WG; Riepe FG; Antonini SR
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3671-5. PubMed ID: 16757525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism.
    Sartorato P; Lapeyraque AL; Armanini D; Kuhnle U; Khaldi Y; Salomon R; Abadie V; Di Battista E; Naselli A; Racine A; Bosio M; Caprio M; Poulet-Young V; Chabrolle JP; Niaudet P; De Gennes C; Lecornec MH; Poisson E; Fusco AM; Loli P; Lombès M; Zennaro MC
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2508-17. PubMed ID: 12788847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
    Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
    Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
    Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
    Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic diversity and correlation with the genotypes of pseudohypoaldosteronism type 1.
    Gopal-Kothandapani JS; Doshi AB; Smith K; Christian M; Mushtaq T; Banerjee I; Padidela R; Ramakrishnan R; Owen C; Cheetham T; Dimitri P
    J Pediatr Endocrinol Metab; 2019 Sep; 32(9):959-967. PubMed ID: 31301676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineralocorticoid receptor mutations and a severe recessive pseudohypoaldosteronism type 1.
    Hubert EL; Teissier R; Fernandes-Rosa FL; Fay M; Rafestin-Oblin ME; Jeunemaitre X; Metz C; Escoubet B; Zennaro MC
    J Am Soc Nephrol; 2011 Nov; 22(11):1997-2003. PubMed ID: 21903996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
    Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.
    Viemann M; Peter M; López-Siguero JP; Simic-Schleicher G; Sippell WG
    J Clin Endocrinol Metab; 2001 May; 86(5):2056-9. PubMed ID: 11344206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nonsense mutation of the mineralocorticoid receptor gene in the renal form of pseudohypoaldosteronism type 1.
    Uchida N; Shiohara M; Miyagawa S; Yokota I; Mori T
    J Pediatr Endocrinol Metab; 2009 Jan; 22(1):91-5. PubMed ID: 19344080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations.
    Escoubet B; Couffignal C; Laisy JP; Mangin L; Chillon S; Laouénan C; Serfaty JM; Jeunemaitre X; Mentré F; Zennaro MC
    Circ Cardiovasc Genet; 2013 Aug; 6(4):381-90. PubMed ID: 23852419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusion of serum- and glucocorticoid-induced kinase 1 (SGK1) as a candidate gene for genetically heterogeneous renal pseudohypoaldosteronism type I in eight families.
    Riepe FG; Holterhus PM
    Am J Nephrol; 2007; 27(2):164-9. PubMed ID: 17317952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel nonsense mutation of the mineralocorticoid receptor gene in a Swedish family with pseudohypoaldosteronism type I (PHA1).
    Nyström AM; Bondeson ML; Skanke N; Mårtensson J; Strömberg B; Gustafsson J; Annerén G
    J Clin Endocrinol Metab; 2004 Jan; 89(1):227-31. PubMed ID: 14715854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.
    Hatta Y; Nakamura A; Hara S; Kamijo T; Iwata J; Hamajima T; Abe M; Okada M; Ushio M; Tsuyuki K; Tajima T
    Endocr J; 2013; 60(3):299-304. PubMed ID: 23197115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autosomal-dominant pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor gene.
    Riepe FG; Krone N; Morlot M; Peter M; Sippell WG; Partsch CJ
    J Clin Endocrinol Metab; 2004 May; 89(5):2150-2. PubMed ID: 15126534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-aldosterone system evaluation over four decades in an extended family with autosomal dominant pseudohypoaldosteronism due to a deletion in the NR3C2 gene.
    Hanukoglu A; Vargas-Poussou R; Landau Z; Yosovich K; Hureaux M; Zennaro MC
    J Steroid Biochem Mol Biol; 2020 Nov; 204():105755. PubMed ID: 33017655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.